COMPOUND MANAGEMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Compound Management Market Size and Trends

The global compound management market is estimated to be valued at USD 436.2 Mn in 2024 and is expected to reach USD 1,140.1 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 14.7% from 2024 to 2031. The market is witnessing significant growth owing to the rising drug discovery activities and the growing need for efficient sample management in pharmaceutical and biotechnology industries.

To learn more about this report, request sample copy

Increasing R&D expenditure by pharmaceutical companies

The global pharmaceutical industry has been witnessing significant investments in research and development over the past few years. While drugs go off-patent and competition intensifies, large pharmaceutical companies are making substantial R&D investments to bring novel therapies to the market. They are exploring new treatment areas and disease pathways through extensive clinical research activities. Continuous development of innovative drug candidates requires efficient management of large chemical libraries and biological sample collections. Pharmaceutical companies are realizing the need for specialized platforms and skilled professionals to properly store, track, retrieve, and distribute compounds and samples involved in various stages of drug discovery and development. This ensures smooth progress of research projects by having desired materials readily available when needed.

Centralized compound management services provide pharmaceutical research organizations the advantage of outsourcing the tasks related to receipt, inventory, storage, and dispensing of research materials. This allows them to focus internal resources on core scientific activities rather than allocating time and money on non-core operational aspects. Such specialized third-party service providers have sophisticated infrastructures and expert personnel to appropriately handle the logistical challenges of compound management. Their automated, standardized processes help maintain sample integrity throughout complex research undertakings. This gives confidence to pharmaceutical companies that valuable research inputs and outputs are protected against any risks of loss, cross-contamination or non-compliance issues. As drug development scales to higher volumes due to open innovation models as well, the demand for reliable compound management is surging in the industry.

Market Concentration and Competitive Landscape

Get actionable strategies to beat competition: Get instant access to report

Technological innovations fueling smart compound management

The compound management market has witnessed robust technological modifications in recent times. Automation solutions have profoundly influenced the way research activities are performed. Advancements such as robotics, RFID tracking, tablet counters, and automated liquid handling systems have enabled higher throughput operations in laboratories. Digital inventories, online ordering interfaces, and streamlined workflows have significantly enhanced the speed, efficiency, and accuracy of compound management. Cloud-based informatics platforms integrate captured data across research sites, allowing real-time visibility, and remote monitoring. Advanced storage systems precisely control environmental conditions as per requirement of stored compounds. Sophisticated analytics tools process vast datasets to glean insights for better decision making.

Overall, technological upgrades are empowering compound management processes with increased productivity, standardized protocols and end-to-end traceability. They establish robust governance mechanisms around compound stewardship that boost client confidence. Novel technologies like 3D-printing will possibly revolutionize sample distribution in future. Emergence of smart labs powered by IoT and machine learning herald the era of predictive and adaptive compound management. Adoption of advanced tools and infrastructure sets industry leaders apart by offering superior quality of service. Technology leveraging also allows cost efficiencies for service providers to be passed on as competitive rates to pharmaceutical industry. Rising capabilities due to continuous innovations stimulate greater outsourcing of Research Materials Management functions globally.

Key Takeaways from Analyst:

The growing pharmaceutical and biotechnology industry and increasing R&D investments for drug discovery are the major drivers propelling the demand for comprehensive sample storage and management solutions. Additionally, the rising drug pipelines, outsourcing of research activities to CROs, and stringent regulatory requirements are fueling the need for automated compound management systems.

North America dominated the market in 2024  and is expected to continue its stronghold during the assessment period. This is attributed to the presence of well-established CROs, biobanks, and pharma companies in the region. However, Asia Pacific is projected to witness the fastest growth and emerge as the most lucrative market due to increasing government funding in life science research and growing outsourcing of clinical trials to China and India.

Adoption of robotic and AI-based solutions presents a big opportunity for market players. In addition, the development of integrated informatics platforms can enhance compound management efficiency. On the other hand, high costs of setting up an automated compound management lab and lack of skilled professionals are some challenges inhibiting faster adoption.Vendors should prioritize developing and offering innovative solutions that meet these evolving demands to stay competitive and address the growing needs of the research and pharmaceutical industries

Market Challenges: High costs involved in installation and implementation of compound management solutions

The global compound management market is facing significant challenges due to the high costs involved in installation and implementation of compound management solutions. Setting up an on-premise compound management system requires huge capital investments for purchasing equipment, software, and hiring trained professionals for system integration and maintenance. Additionally, implementation of such complex systems is a lengthy and expensive process. It involves substantial expenses for customizing the system as per specific workflow and operational requirements of individual organizations. The high costs become a major hindrance especially for small to mid-sized companies and research laboratories to automate their compound management operations. The significant financial investments discourage various end-users from adopting robust compound management systems in their facilities.

Market Opportunities: Outsourcing of compound/sample management services

The global compound management market is witnessing new opportunities from the rising trend of outsourcing compound/sample management services. Numerous pharma and biotech companies are outsourcing their compound storage and related activities to specialty third-party service providers. This is helping to reduce costs and improve operational efficiency for organizations. The outsourcing service providers have state-of-the-art facilities with all the necessary equipment and trained personnel to properly handle, store, analyze, and distribute various compounds and samples on behalf of their clients. They leverage economies of scale to offer these services at competitive rates. This is proving beneficial for companies to focus on their core operations while a specialist provider takes care of their compound management requirements. The outsourcing market offers flexibility, compliance, and cost savings which are driving increased adoption of third-party services in the industry.

Discover high revenue pocket segments and roadmap to it: Get instant access to report

By Compound Type - Increased adoption of small molecule drug discovery

In terms of compound type , small molecules contributes the highest share of the market with 40 % in 2024 owing to several factors. Small molecule drugs are relatively easier to produce at scale for widespread clinical testing and commercial use compared to biologics or cell lines. This allows pharmaceutical companies to pursue extensive drug discovery programs centered around screening large libraries of small molecule compounds. Furthermore, optimization and refinement of lead small molecule hits into drug candidates suitable for later stage development is a more established process compared to other compound classes. Several blockbuster drug classes such as antibiotics, anti-hypertensives, and anti-depressants have been developed as small molecules over decades of R&D, creating a positive precedent and feedback loop driving continued research in this segment. Additionally, automation technologies have enabled high-throughput screening of very large compound collections against disease relevant targets at an unprecedented pace. This has boosted productivity and efficiency of small molecule focused drug discovery programs. Favorable return on investment prospects along proven drug development pathways will ensure small molecules remain the dominant compound class pursued by pharma industry in the foreseeable future.

By Type - Advantage of integrated hardware and software platforms

In terms of type, product contributes the highest share of the market with 60% in 2024 owing to the advantages offered by integrated hardware and software platforms. Vendors in recent years have focused on developing fully automated, high-capacity systems that allow for walkaway sample handling for extended periods. This has led to companies consolidating automation equipment, liquid handling apparatus, robotic arms, and cold storage functionalities into single, scalable platforms controlled by sophisticated inventory management software. Such integrated solutions minimize manual human errors and biological sample attrition rates while improving traceability. They facilitate round-the-clock operations and high-throughput screening needs of modern drug discovery. Preference for 'one-stop-shop' products that integrate diverse functionalities via seamless software interfaces saves on procurement, installation and maintenance costs of individual components. Established product brands with proven track-record of performance and compliance with regulatory standards provide labs confidence in opting for complete integrated solutions meeting their specific compound management requirements.

By Application - Extensive applicability across entire drug R&D spectrum

In terms of application, drug discovery contributes the highest share of the market with 40.2% in 2024 due to the extensive utilization of compound management across the entire spectrum of drug research and development workflow. Right from primary and secondary screening of compound libraries against disease-specific molecular targets, through hit-to-lead and preclinical candidate optimization phases, efficient compound management remains critically important. As drug candidates progress to various in vitro and in vivo testing stages, proper sample storage, organization, and documentation assumes increased significance. Later during regulatory filings, maintaining chain of custody on all experimental compounds and their corresponding raw data is paramount. Finally, as new chemical entities receive approvals, compound collection and distribution aids commercialization. Given the long drug development timelines and capital investments, effective management of screening compounds and their associated metadata allows the continuous mining of past results and informed decision making. This drives majority of compound management spending to focus on the resource and data-intensive drug discovery segment.

Regional Insights

To learn more about this report, request sample copy

North America has established itself as the dominant region in the global compound management market with share of 39.20% in 2024. The region is home to many top pharmaceutical companies and Contract Research Organizations (CROs) that are major end-users of compound management solutions. Countries like the U.S. have a large number of drug discovery and development activities taking place, driving the need for efficient compound management across various stages of the drug development lifecycle. Additionally, North America has seen significant adoption of automation and integration technologies in research workflows, further fueling the demand for high-throughput compound management platforms.

The region also has a well-established pharmaceutical manufacturing sector with the presence of top drug makers. Since compound libraries form the starting point for new drug syntheses, pharmaceutical manufacturers in North America rely heavily on compound management systems. Industry leaders are focusing on developing innovative features like artificial intelligence and robotics in their compound management offerings to enhance the capabilities of their customers. All these factors have made North America the largest market for compound management globally.

The Asia Pacific region has emerged as the fastest growing market for compound management. Countries such as China, India, and South Korea witnessed a rapid expansion of their pharmaceutical industries in the past decade. There is a growing emphasis on home-grown drug discovery and manufacturing capabilities in these markets. This has prompted many global CROs and pharmaceutical vendors to establish R&D centers and manufacturing plants in Asia Pacific. The increasing outsourcing of clinical research as well as generic and biosimilar drug development to Asia Pacific is also boosting demand. Furthermore, Asia Pacific governments are supporting their local industries through initiatives focused on enhancing scientific skills and infrastructure. These favorable conditions are attracting significant capital investments towards advancing pharmaceutical research activities in the region. As a result, the Asia Pacific compound management market is projected to experience strong double digit growth over the coming years.

Market Report Scope

Key Developments

• In November 2023, Sygnature Discovery invested £3.75 million in a new Azenta compound management storage system. This state-of-the-art technology enhances hit-finding capabilities and offers pharma and biotech clients the option to store their compound libraries.
• In May 2023, eMolecules, Inc. acquired Specs Compound Handling B.V., a company specializing in chemical compound management for the life sciences sector. Specs enhances time and cost efficiency in large-scale drug screening programs, particularly in Europe’s pharmaceutical, biotechnology, and academic fields.
• In June 2022, TTP, a leading technology and product development company in Europe, and Ionomr Innovations Inc., a specialist in next-generation ion-exchange membranes and polymers for clean energy, announced a collaboration to showcase a new green hydrogen electrolyzer intended for mass production
• In December 2021, BICO acquired Biosero, a top software company for automated processes and lab connections, for up to US$ 20 million over three years. The deal, with 63% paid in cash, 21% in shares, and 16% as an earnout, aims to boost Biosero’s commercial growth and expand into new markets.
• In February 2021, SPT Labtech acquired BioMicroLab, enhancing its sample management capabilities in the life sciences sector

*Definition: The global compound management market offers solutions for the storage, inventory management, and dispensing of chemical and biological samples. These systems enable life science researchers to efficiently track and retrieve compounds and reagents through automation, accelerating drug discovery. By streamlining the receipt, storage, inventory, and dispensing of valuable compound libraries, compound management systems enhance laboratory productivity.

Market Segmentation

• Compound Type Insights (Revenue, USD Mn, 2019 - 2031)
• • Small Molecules
  • Biologics
  • Nucleic Acids
  • Cell Lines
  • Others
•  Type Insights (Revenue, USD Mn, 2019 - 2031)
  • Product
    • Automated Compound/ Sample Storage System
    • Automated Liquid Handling Systems
    • Others
  • Services
    • Compound Sourcing and Acquisition
    • Compound Reformatting and Normalization
    • Compound Quantification and Qualification
    • Compound Retrieval and Distribution
    • Compound Inventory and Data Management
    • Others
•  Application Insights (Revenue, USD Mn, 2019 - 2031)
  • Drug Discovery
  • Drug Development
  • Chemical Biology Research
  • Biobanking
  • Forensics and Toxicology
  • Others
•  End-user Insights (Revenue, USD Mn, 2019 - 2031)
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Academic and Research Institutes
  • Forensic Laboratories
  • Other End-Users
• Regional Insights (Revenue, USD Mn, 2019 - 2031)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • TCG Lifesciences
  • Wuxi Apptec
  • Icagen
  • Evotec
  • Biosero
  • Labcyte
  • TTP Group
  • Hamilton Company
  • Tecan
  • Brooks Automation
  • Frontier Scientific
  • Brooks Life Sciences
  • Titian Software Limited
  • Beckman Coulter, Inc.
  • BioAscent
  • LiCONiC AG
  • SPT Labtech
  • Tecan Trading AG